For the Inventor, By the Inventor

Enter inventor name

Shanghai, China

Ke Liu

USPTO Granted Patents = 22 (Patent Applications = 11)

EPO Patents = 2 (Patent Applications = 11)

Average Co-Inventor Count = 3.1

ph-index = 3

Forward Citations = 29(Granted Patents)

Company Filing History:

Accutar Biotechnology Inc.

Sharkgulf Technology (Qingdao) Co., Ltd.

Keiper Seating Mechanisms Co., Ltd.

Tiger Biotherapeutics Inc.

Years Active: 2018-2025

Loading Chart...

Loading Chart...

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12428091 - Early-warning system, method and device for steering of two-wheeled vehicle, and corresponding two-wheeled vehicle (2025-09-30),

2. 12263854 - Double independent control unit-based intelligent vehicle control system and vehicle (2025-04-01),

3. 12192569 - Audio information transmission system, method, device, corresponding two wheeled vehicle, and helmet (2025-01-07),

4. 12168058 - Glutarimide-containing KRAS-mutant degrader compounds and uses thereof (2024-12-17),

5. 11535606 - Substituted quinoline-8-carbonitrile derivatives with androgen receptor degradation activity and uses thereof (2022-12-27),

6. 11530222 - Substituted pyrrolopyrimidine and pyrazolopyrimidine as Bruton's tyrosine kinase (BTK) degraders (2022-12-20),

7. 11521712 - Computational method for classifying and predicting ligand docking conformations (2022-12-06),

8. 11453313 - Memory module and seat mounting structure with easy entry module (2022-09-27),

9. 11420956 - Ureas having Androgen Receptor degradation activity and uses thereof (2022-08-23),

10. 11312702 - Substituted quinoline-8-carbonitrile derivatives having androgen receptor degradation activity and uses thereof (2022-04-26),

11. 11261178 - Chroman derivatives having estrogen receptor degradation activity and uses thereof (2022-03-01),

12. 11220490 - Ureas having androgen receptor degradation activity and uses thereof (2022-01-11),

13. 11117885 - Compounds having estrogen receptor alpha degradation activity and uses thereof (2021-09-14),

14. 10968212 - Compounds having estrogen receptor alpha degradation activity and uses thereof (2021-04-06),

15. 10923214 - Neural network for predicting drug property (2021-02-16),

Title: The Innovative Journey of Ke Liu

Introduction: Ke Liu is a pioneering inventor based in Shanghai, China, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Ke Liu holds several patents in various technological domains, including artificial intelligence, renewable energy, and biotechnology, showcasing his diverse expertise and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Ke Liu has established himself as a prominent figure in the innovation landscape, consistently pushing the boundaries of what is possible through his inventive spirit and dedication to progress.

Collaborations: Throughout his career, Ke Liu has collaborated with leading research institutions, universities, and tech companies, fostering a culture of innovation and knowledge-sharing that has led to the development of cutting-edge technologies with real-world applications.

Conclusion: Ke Liu's relentless pursuit of innovation and his commitment to creating a better future through his inventions make him a true visionary in the world of technology, inspiring the next generation of inventors to dream big and think outside the box.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…